COLLAGEN-SPECIFIC ENZYME WITH PLATELET AGGREGATION INHIBITION PROPERTIES

The collagenase is like tissue collagenases in that it cleaves collagen at a single site. The collagenase which has a molecular weight of about 50k daltons, specifically inhibits collagen-induced platelet aggregation, with substantially no effect on platelet count or size, and may be used alone or t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LEVY, HAIM, SAWYER, ROY, THOMAS, RIGBI, MEIR, IRAKI, FUAD
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LEVY, HAIM
SAWYER, ROY, THOMAS
RIGBI, MEIR
IRAKI, FUAD
description The collagenase is like tissue collagenases in that it cleaves collagen at a single site. The collagenase which has a molecular weight of about 50k daltons, specifically inhibits collagen-induced platelet aggregation, with substantially no effect on platelet count or size, and may be used alone or together with another platelet aggregation inhibitor. The latter may also be a leech-derived biochemical, such as an apyrase, or an inhibitor of the release of platelet aggregation factor by leucocytes. La collagénase est comme les collagénases tissulaires dans la mesure où elle effectue le clivage du collagène en un seul site. La collagénase, qui possède un poids moléculaire d'environ 50k daltons, inhibe de manière spécifique l'agrégation des plaquettes induites par le collagène, avec pratiquement aucun effet sur le comptage ou les dimensions des plaquettes, et elle peut être utilisée seule ou avec un autre inhibiteur de l'agrégation des plaquettes. Ce dernier peut être aussi un agent biochimique dérivé des sangsues, tel qu'une apyrase, ou un inhibiteur de la libération du facteur d'agrégation des plaquettes par des leucocytes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO8700860A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO8700860A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO8700860A13</originalsourceid><addsrcrecordid>eNrjZPBw9vfxcXR39dMNDnB19nTzdFZw9YuK9HVVCPcM8VAI8HEMcfVxDVFwdHcPcnV3DPH091Pw9PPwdPIEMwOC_ANcg0I8XYN5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakl8uL-FuYGBhZmBo6ExEUoA3C8s_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COLLAGEN-SPECIFIC ENZYME WITH PLATELET AGGREGATION INHIBITION PROPERTIES</title><source>esp@cenet</source><creator>LEVY, HAIM ; SAWYER, ROY, THOMAS ; RIGBI, MEIR ; IRAKI, FUAD</creator><creatorcontrib>LEVY, HAIM ; SAWYER, ROY, THOMAS ; RIGBI, MEIR ; IRAKI, FUAD</creatorcontrib><description>The collagenase is like tissue collagenases in that it cleaves collagen at a single site. The collagenase which has a molecular weight of about 50k daltons, specifically inhibits collagen-induced platelet aggregation, with substantially no effect on platelet count or size, and may be used alone or together with another platelet aggregation inhibitor. The latter may also be a leech-derived biochemical, such as an apyrase, or an inhibitor of the release of platelet aggregation factor by leucocytes. La collagénase est comme les collagénases tissulaires dans la mesure où elle effectue le clivage du collagène en un seul site. La collagénase, qui possède un poids moléculaire d'environ 50k daltons, inhibe de manière spécifique l'agrégation des plaquettes induites par le collagène, avec pratiquement aucun effet sur le comptage ou les dimensions des plaquettes, et elle peut être utilisée seule ou avec un autre inhibiteur de l'agrégation des plaquettes. Ce dernier peut être aussi un agent biochimique dérivé des sangsues, tel qu'une apyrase, ou un inhibiteur de la libération du facteur d'agrégation des plaquettes par des leucocytes.</description><edition>4</edition><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1987</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19870212&amp;DB=EPODOC&amp;CC=WO&amp;NR=8700860A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19870212&amp;DB=EPODOC&amp;CC=WO&amp;NR=8700860A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LEVY, HAIM</creatorcontrib><creatorcontrib>SAWYER, ROY, THOMAS</creatorcontrib><creatorcontrib>RIGBI, MEIR</creatorcontrib><creatorcontrib>IRAKI, FUAD</creatorcontrib><title>COLLAGEN-SPECIFIC ENZYME WITH PLATELET AGGREGATION INHIBITION PROPERTIES</title><description>The collagenase is like tissue collagenases in that it cleaves collagen at a single site. The collagenase which has a molecular weight of about 50k daltons, specifically inhibits collagen-induced platelet aggregation, with substantially no effect on platelet count or size, and may be used alone or together with another platelet aggregation inhibitor. The latter may also be a leech-derived biochemical, such as an apyrase, or an inhibitor of the release of platelet aggregation factor by leucocytes. La collagénase est comme les collagénases tissulaires dans la mesure où elle effectue le clivage du collagène en un seul site. La collagénase, qui possède un poids moléculaire d'environ 50k daltons, inhibe de manière spécifique l'agrégation des plaquettes induites par le collagène, avec pratiquement aucun effet sur le comptage ou les dimensions des plaquettes, et elle peut être utilisée seule ou avec un autre inhibiteur de l'agrégation des plaquettes. Ce dernier peut être aussi un agent biochimique dérivé des sangsues, tel qu'une apyrase, ou un inhibiteur de la libération du facteur d'agrégation des plaquettes par des leucocytes.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1987</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBw9vfxcXR39dMNDnB19nTzdFZw9YuK9HVVCPcM8VAI8HEMcfVxDVFwdHcPcnV3DPH091Pw9PPwdPIEMwOC_ANcg0I8XYN5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakl8uL-FuYGBhZmBo6ExEUoA3C8s_A</recordid><startdate>19870212</startdate><enddate>19870212</enddate><creator>LEVY, HAIM</creator><creator>SAWYER, ROY, THOMAS</creator><creator>RIGBI, MEIR</creator><creator>IRAKI, FUAD</creator><scope>EVB</scope></search><sort><creationdate>19870212</creationdate><title>COLLAGEN-SPECIFIC ENZYME WITH PLATELET AGGREGATION INHIBITION PROPERTIES</title><author>LEVY, HAIM ; SAWYER, ROY, THOMAS ; RIGBI, MEIR ; IRAKI, FUAD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO8700860A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1987</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LEVY, HAIM</creatorcontrib><creatorcontrib>SAWYER, ROY, THOMAS</creatorcontrib><creatorcontrib>RIGBI, MEIR</creatorcontrib><creatorcontrib>IRAKI, FUAD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LEVY, HAIM</au><au>SAWYER, ROY, THOMAS</au><au>RIGBI, MEIR</au><au>IRAKI, FUAD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COLLAGEN-SPECIFIC ENZYME WITH PLATELET AGGREGATION INHIBITION PROPERTIES</title><date>1987-02-12</date><risdate>1987</risdate><abstract>The collagenase is like tissue collagenases in that it cleaves collagen at a single site. The collagenase which has a molecular weight of about 50k daltons, specifically inhibits collagen-induced platelet aggregation, with substantially no effect on platelet count or size, and may be used alone or together with another platelet aggregation inhibitor. The latter may also be a leech-derived biochemical, such as an apyrase, or an inhibitor of the release of platelet aggregation factor by leucocytes. La collagénase est comme les collagénases tissulaires dans la mesure où elle effectue le clivage du collagène en un seul site. La collagénase, qui possède un poids moléculaire d'environ 50k daltons, inhibe de manière spécifique l'agrégation des plaquettes induites par le collagène, avec pratiquement aucun effet sur le comptage ou les dimensions des plaquettes, et elle peut être utilisée seule ou avec un autre inhibiteur de l'agrégation des plaquettes. Ce dernier peut être aussi un agent biochimique dérivé des sangsues, tel qu'une apyrase, ou un inhibiteur de la libération du facteur d'agrégation des plaquettes par des leucocytes.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_WO8700860A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title COLLAGEN-SPECIFIC ENZYME WITH PLATELET AGGREGATION INHIBITION PROPERTIES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T18%3A34%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LEVY,%20HAIM&rft.date=1987-02-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO8700860A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true